Pharmacodynamic and kinetic basis for the selection of pneumococcal resistance in the upper respiratory tract

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue SUPPL. 2, 2002, Pages 51-58

  Soriano, Francisco ^a   Rodriguez Cerrato, Violeta ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ENOXACIN; ERYTHROMYCIN; ERYTHROMYCIN ESTOLATE; ERYTHROMYCIN PROPIONATE; ERYTHROMYCIN STEARATE; LEVOFLOXACIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFAMETHOXAZOLE; SULFONAMIDE; TELITHROMYCIN; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG PENETRATION; DRUG POTENCY; DRUG TARGETING; DRUG TISSUE LEVEL; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OROPHARYNX; PATHOGENESIS; REVIEW; SALIVARY GLAND; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; RESPIRATORY TRACT INFECTIONS; SALIVA; STREPTOCOCCUS PNEUMONIAE;

EID: 0036980163     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Barza, M. (1994). Challenges to antibiotic activity in tissue. Clinical Infectious Diseases 19, 910-5.
2. Haeckel, R. & Hanecke, P. (1996). Application of saliva for drug monitoring. An in vivo model for transmembrane transport. European Journal of Clinical Chemistry and Clinical Biochemistry 34, 171-91.
3. Stjernquist-Desatnick, A., Samuelsson, P. & Walder, M. (1993). Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis. Journal of Laryngology and Otology 107, 309-12.
4. Nelson, J. D., Ginsburg, C. M., Mcleland, O., Clahsen, J., Culbertson, M. C., Jr & Carder, H. (1981). Concentrations of antimicrobial agents in middle ear fluid, saliva and tears. International Journal of Pediatric Otorhinolaryngology 3, 327-34.
5. Nord, C. E. & Heimdahl, A. (1986). Impact of orally administered antimicrobial agents on human oropharyngeal and colonic microflora. Journal of Antimicrobial Chemotherapy 18, Suppl. C, 159-64.
6. Wust, J. & Hardegger, U. (1993). Penetration of clarithromycin into human saliva. Chemotherapy 39, 293-6.
7. Nord, C. E., Heimdahl, A., Lundberg, C. & Marklund, G. (1987). Impact of cefaclor on the normal human oropharyngeal and intestinal microflora. Scandinavian Journal of Infectious Diseases 19, 681-5.
8. Havard, C. W. H., Bax, R. P., Samanta, T. C., Pearson, R. M., Brumfitt, W., Hamilton-Miller, J. M. T. et al. (1980). Sputum and blood concentrations of cefuroxime in lower respiratory tract infection. Thorax 35, 379-83.
9. Zhou, H. H., Chan, Y. P., Arnold, K. & Sun, M. (1985). Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults. Antimicrobial Agents and Chemotherapy 27, 192-6.
10. Kamme, C., Melander, A. & Nilsson, N. I. (1983). Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: relation between saliva concentrations and in vitro activity against nasopharyngeal pathogens. Scandinavian Journal of Infectious Diseases 15, 107-13.
11. Brumfitt, W., Hamilton-Miller, J. M. T., Havard, C. W. & Tansley, H. (1985). Trimethoprim alone compared to co-trimoxazole in lower respiratory infections: pharmacokinetics and clinical effectiveness. Scandinavian Journal of Infectious Diseases 17, 99-105.
12. Ducci, M., Scalori, V., del Tacca, M., Soldani, G., Bernardini, C., Grothe, E. et al. (1981). The pharmacokinetics of two erythromycin esters in plasma and in saliva following oral administration in humans. International Journal of Clinical Pharmacology, Therapy, and Toxicology 19, 494-7.
13. Henry, J., Turner, P., Garland, M. & Esmieu, F. (1980). Plasma and salivary concentrations of erythromycin after administration of three different formulations. Postgraduate Medical Journal 56, 707-10.
14. Tuominen, R. K., Männistö, P. T., Solkinen, A., Vuorela, A., Pohto, P. & Haataja, H. (1988). Antibiotic concentration in suction skin blister fluid and saliva after repeated dosage of erythromycin acistrate and erythromycin base. Journal of Antimicrobial Chemotherapy 21, Suppl. D, 57-65.
15. Geerdes-Fenge, H. F., Goetschi, B., Rau, M., Borner, K., Koeppe, P., Wettich, K. et al. (1997). Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva. European Journal of Clinical Pharmacology 53, 127-33.
16. McCracken, G. H., Jr, Ginsburg, C. M., Zweighaft, T. C. & Clahsen, J. (1980). Pharmacokinetics of rifampin in infants and children: relevance to prophylaxis against Haemophilus influenzae type b disease. Pediatrics 66, 17-21.
17. Blandizzi, C., Malizia, T., Lupetti, A., Pesce, D., Gabriele, M., Giuca, M. R. et al. (1999). Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. Journal of Periodontology 70, 960-6.
18. Malizia, T., Tejada, M. R., Ghelardi, E., Senesi, S., Gabriele, M., Giuca, M. R. et al. (1997). Periodontal tissue disposition of azithromycin. Journal of Periodontology 68, 1206-9.
19. Edlund, C., Alván, G., Barkholt, L., Vacheron, F & Nord, C. E. (2000). Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora. Journal of Antimicrobial Chemotherapy 46, 741-9.
20. Kees, F., Wellenhofer, M. & Grobecker, H. (1995). Serum and cellular pharmacokinetics of clarithromycin 500 mg q.d. and 250 mg b.i.d. in volunteers. Infection 23, 168-72.
21. Piercy, E. A., Bawdon, R. E. & Mackowiak, P. A. (1989). Penetration of ciprofloxacin into saliva and nasal secretions and effect of the drug on the oropharyngeal flora of ill subjects. Antimicrobial Agents and Chemotherapy 33, 1645-6.
22. Heikkinen, T., Saeed, K. A., McCormick, D. P., Baldwin, C., Reisner, B. S. & Chonmaitree, T. (2000). A single intramuscular dose of ceftriaxone changes nasopharyngeal bacterial flora in children with acute otitis media. Acta Paediatrica 89, 1316-21.
23. Brismar, B., Edlund, C. & Nord, C. E. (1993). Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora. European Journal of Clinical Microbiology and Infectious Diseases 12, 714-9.
24. Heimdahl, A., Kager, L. & Nord, C. E. (1985). Changes in the oropharyngeal and colon microflora in relation to antimicrobial concentrations in saliva and faeces. Scandinavian Journal of Infectious Diseases Supplementum 44, 52-8.
25. Cavallaro, V., Catania, V., Bonaccorso, R., Mazzone, S., Speciale, A., Di Marco, R. et al. (1992). Effect of a broad-spectrum cephalosporin on the oral and intestinal microflora in patients undergoing colorectal surgery. Journal of Chemotherapy 4, 82-7.
26. Lund, B., Edlund, C., Rynnel-Dagoo, B., Lundgren, Y., Sterner, J. & Nord, C. E. (2001). Ecological effects on the oro- and nasopharyngeal microflora in children after treatment of acute otitis media with cefuroxime axetil or amoxycillin-clavulanate as suspensions. Clinical Microbiology and Infection 7, 230-7.
27. Edlund, C. & Nord, C. E. (1988). A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora. Infection 16, 8-12.
28. Chapalain, J. C., Dusseau, J. Y., Perrier-Gros-Claude, J. D., Rouby, Y. & Bartoli, M. (1994). Effect of rifampicin chemoprophylaxis on the aerobic bacterial flora of the oropharynx. Journal of Antimicrobial Chemotherapy 33, 151-5.
29. MacGregor, A. J. & Hart, P. (1986). The effect of a single large dose of amoxycillin on oral streptococci. Journal of Antimicrobial Chemotherapy 18, 113-7.
30. de Vries-Hospers, H. G., Tonk, R. H. & van der Waaij, D (1991). Effect of intramuscular ceftriaxone on aerobic oral and faecal flora of 11 healthy volunteers. Scandinavian Journal of Infectious Diseases 23, 625-33.
31. Edlund, C., Sjostedt, S. & Nord, C. E. (1997). Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora. Scandinavian Journal of Infectious Diseases 29, 383-6.
32. de Vries-Hospers, H. G., Welling, G. W. & van der Waaij, D. (1987). Influence of quinolones on throat- and faecal flora of healthy volunteers. Pharmaceutish Weekblad Scientific Edition 9, Suppl., 41-4.
33. Edlund, C., Alvan, G., Barkholt, L., Vacheron, F. & Nord, C. E. (2000). Pharmacokinetics and comparative effect of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal flora. Journal of Antimicrobial Chemotherapy 46, 741-9.
34. Cohen, R., Bingen, E., Varon, E., de La Rocque, F., Brahimi, N., Levy, C. et al. (1997). Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatric Infectious Disease Journal 16, 555-60.
35. Dabernat, H., Geslin, P., Megraud, F., Bégué, P., Boulesteix, J., Dubreuil, C. et al. (1998). Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. Journal of Antimicrobial Chemotherapy 41, 253-8.
36. Dagan, R., Leibovitz, E., Greenberg, D., Yagupsky, P., Fliss, D. M. & Leiberman, A. (1998). Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatric Infectious Disease Journal 17, 880-5.
37. Ghaffar, F., Muniz, L. S., Katz, K., Reynolds, J., Smith, J. L., Davis, P. et al. (2000). Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. Clinical Infectious Diseases 31, 875-80.
38. Brook, I. & Gober, A. E. (1996). Prophylaxis with amoxicillin or sulfisoxazole for otitis media: effect on the recovery of penicillin-resistant bacteria from children. Clinical Infectious Diseases 22, 143-5.
39. Cohen, R., Navel, M., Grunberg, J., Boucherat, M., Geslin, P., Derriennic, M. et al. (1999). One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora. Pediatric Infectious Disease Journal 18, 403-9.
40. Varon, E., Levy, C., de La Rocque, D., Boucherat, M., Deforche, D., Podglajen, I. et al. (2000). Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections. Clinical Infectious Diseases 31, 477-81.
41. Samore, M. H., Magill, M. K., Alder, S. C., Severina, E., Morrison-de Boer, L., Lyon, L. et al. (2001). High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics 108, 856-65.
42. Negri, M. C., Morosini, M. I., Loza, E. & Baquero, F. (1994). In vitro selective antibiotic concentrations of β-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrobial Agents and Chemotherapy 38, 122-5.
43. Baquero, F. (1996). Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 117-32.
44. Morita, J. Y., Kahn, E., Thompson, T., Laclaire, L., Beall, B., Gherardi, G. et al. (2000). Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae. Pediatric Infectious Disease Journal 19, 41-6.
45. Leach, A. J., Shelby-James, T. M., Mayo, M., Gratten, M., Laming, A. C., Currie, B. J. et al. (1997). A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clinical Infectious Diseases 24, 356-62.
46. Abdel-Haq, N., Abuhammour, W., Asmar, B., Thomas, R., Dabbah, S. & Gonzalez, R. (1999). Nasopharyngeal colonization with Streptococcus pneumoniae in children receiving trimethoprim-sulfamethoxazole prophylaxis. Pediatric Infectious Disease Journal 18, 647-9.
47. Arason, V. A., Kristinsson, K. G., Sigurdsson, J. A., Stefansdottir, G., Molstad, S. & Gudmundsson, S. (1996). Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross-sectional prevalence study. British Medical Journal 313, 387-91.
48. Kristinsson, K. G., Hjalmarsdottir, M. A. & Gudnason, T. H. (1998). Continued decline in incidence of penicillin non-susceptible pneumococci in Iceland. In Program and Abstracts of the Thirty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA, 1998. Abstract C-22, p. 74. American Society for Microbiology, Washington, DC, USA.
49. Guillemot, D., Carbon, C., Balkau, B., Geslin, P., Lecoeur, H., Vauzelle-Kervroëdan, F. et al. (1998). Low dosage and long treatment duration of β-lactam. Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. Journal of the American Medical Association 279, 365-370.
50. Schrag, S. J., Pena, C., Fernandez, J., Sanchez, J., Gomez, V., Perez, E. et al. (2001). Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage. A randomized trial. Journal of the American Medical Association 286, 49-56.
51. Guillemot, D., Henriet, L., Laurent, C., Lecoeur, H., Weber, P. & Carbon, C. (2001). Optimization of antibiotic use rapidly decreases penicillin resistant Streptococcus pneumoniae (PRSP) carriage: the AUBEPPIN study. In Program and Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, 2001. Abstract G-1527, p. 264. American Society for Microbiology, Washington, DC, USA.
52. Baquero, F. (1999). Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption. Journal of Chemotherapy 11, 35-43.
53. Felmingham, D. & Grüneberg, R. N. (1996). A multicentre, collaborative study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens 1992-1993: the Alexander Project. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 1-57.
54. Dagan, R., Klugman, K. P., Craig, W. A. & Baquero, F. (2001) Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. Journal of Antimicrobial Chemotherapy 47, 129-40.
55. Craig, W. A. (2001). Does the dose matter? Clinical Infectious Diseases 33, Suppl. 3, 233-7.
56. Drusano, G. L. & Goldstein, F. W. (1996). Relevance of the Alexander Project: pharmacodynamic considerations. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 141-54.
57. Craig, W. A. (2001). Re-evaluating current antibiotic therapy. Respiratory Medicine 95, Suppl. A, 12-9.
58. Dong, Y., Zhao, X., Kreiswirth, B. N. & Drlica, K. (2000). Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 44, 2581-4.
59. Blondeau, J. M., Zhao, X., Hansen, G. & Drlica, K. (2001). Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 45, 433-8.
60. Allen, G. P. & Rybak, M. J. (2001). Comparative activity of mutant prevention concentration (MPC)-derived dosages of moxifloxacin (MXF) and levofloxacin (LEV) against Streptococcus pneumoniae in an in vitro pharmacodynamic model (IVPM). In Program and Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, 2001. Abstract A-438, p. 10. American Society for Microbiology, Washington, DC, USA.
61. max, MPC and MIC for the killing of Streptococcus pneumoniae by gatifloxacin (GA), gemifloxacin (GM), levofloxacin (L) and moxifloxacin (M). In Program and Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, 2001. Abstract A-2079, p. 30. American Society for Microbiology, Washington, DC, USA.
62. Ekdahl, K., Ahlinder, I., Hansson, H. B., Melander, E., Mölstad, S., Söderström, M. et al. (1997). Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project. Clinical Infectious Diseases 25, 1113-7.
63. Dagan, R. & Fraser, D. (2000). Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immunity and reduction of otitis morbidity. Pediatric Infectious Disease Journal 19, S79-88.